TickerCompare

NVO logoNovo Nordisk

NVO·Novo Nordisk A/S·Denmark

Danish maker of Ozempic/Wegovy - the original GLP-1 weight-loss drugs. Worldwide demand.

1-year return
-20.3%
5-year return
+24.5%
Avg / year
+4.5%
annualised
Trades in
USD
Denmark
Pharma & biotech
-over the past year
Loading chart…
Worst drop
-
Volatility / yr
-
Compare with

Returns shown in USD. Past performance is not a reliable guide to future results. Owning a single stock is riskier than a diversified fund.

Novo Nordisk head to head

Similar stocks

Interactive Brokers

Available on Interactive Brokers

Buy Novo Nordisk and thousands of other stocks and ETFs on Interactive Brokers.

Affiliate link. We may earn a referral commission, at no cost to you.

Frequently asked questions

Can I buy NVO on Interactive Brokers?

Yes. Novo Nordisk (NVO) is a Denmark company available to investors worldwide through Interactive Brokers (IBKR), which is a popular low-cost way to buy overseas shares thanks to its low FX conversion cost and low trading commissions.

What does Novo Nordisk do?

Danish maker of Ozempic/Wegovy - the original GLP-1 weight-loss drugs. Worldwide demand.

What currency does NVO trade in?

NVO trades in USD. On TickerCompare its chart and returns are converted to US dollars so you can compare it on the same basis as every other stock and ETF on the site.

Is NVO a risky investment?

Owning a single company like Novo Nordisk is riskier than owning a diversified fund: if this one business stumbles there is nothing else in the holding to cushion it, and single stocks can swing far more than a broad ETF. Most beginners keep individual names to a small slice of a mostly fund-based portfolio.